Bright Minds Biosciences Inc. Form 6-K Report: Key Updates & Compliance Insights

Here are the key insights extracted from the provided section of the financial report:

1. Document Type: The filing is a Form 6-K, which is typically used by foreign private issuers to report significant events or financial information to the SEC.
2. Company Information:

• Name: Bright Minds Biosciences Inc.
• Address: 19 Vestry Street, New York, NY 10013.

3. Filing Details:

• Commission File Number: 001-40997.
• Filing Date: January 7, 2025.

4. Report Purpose: The report is submitted pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, indicating compliance with SEC regulations for reporting significant events.
5. Annual Report Filing: The company indicated that it will file annual reports under Form 20-F (checked) and not Form 40-F (unchecked).
6. Exhibit Included:

• The filing includes Exhibit 99.1, which is a news release dated January 7, 2025. This may contain important updates or announcements relevant to the company.

7. Signature: The report is signed by Ian McDonald, President and CEO of Bright Minds Biosciences Inc., confirming the authenticity of the submission.

This information is crucial for stakeholders and analysts tracking the company's compliance, operational updates, and financial disclosures.